Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Caligaris Cappio

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Journal of Clinical Immunology|November 1, 1985
Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activityF Malavasi, A Funaro, G Bellone, et al.
Cellular Immunology|February 1, 1986
Definition by CB12 monoclonal antibody of a differentiation marker specific for human monocytes and their bone marrow precursorsF Malavasi, A Funaro, G Bellone, et al.
Leukemia Research|January 1, 1984
Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPAF Caligaris-Cappio, G Janossy, D Campana, et al.
Clinical Immunology and Immunopathology|April 1, 1995
Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigensF Dazzi, E D'Andrea, G Biasi, et al.
Clinical and Experimental Immunology|October 1, 1987
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodiesP L Tazzari, M Gobbi, A Dinota, et al.
British Journal of Haematology|September 1, 1996
In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosisD Gottardi, A Alfarano, A M De Leo, et al.
Leukemia Research|March 10, 1999
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformationA Stacchini, M Aragno, A Vallario, et al.
Blood|March 26, 1999
An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemiaA Alfarano, S Indraccolo, P Circosta, et al.
British Journal of Cancer|July 2, 2009
Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumoursV Gregorc, A Santoro, E Bennicelli, et al.
Leukemia|November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factorR Zanotti, A Ambrosetti, M Lestani, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Journal of Clinical Immunology|November 1, 1985
Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activityF Malavasi, A Funaro, G Bellone, et al.
Cellular Immunology|February 1, 1986
Definition by CB12 monoclonal antibody of a differentiation marker specific for human monocytes and their bone marrow precursorsF Malavasi, A Funaro, G Bellone, et al.
Leukemia Research|January 1, 1984
Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPAF Caligaris-Cappio, G Janossy, D Campana, et al.
Clinical Immunology and Immunopathology|April 1, 1995
Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigensF Dazzi, E D'Andrea, G Biasi, et al.
Clinical and Experimental Immunology|October 1, 1987
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodiesP L Tazzari, M Gobbi, A Dinota, et al.
British Journal of Haematology|September 1, 1996
In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosisD Gottardi, A Alfarano, A M De Leo, et al.
Leukemia Research|March 10, 1999
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformationA Stacchini, M Aragno, A Vallario, et al.
Blood|March 26, 1999
An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemiaA Alfarano, S Indraccolo, P Circosta, et al.
British Journal of Cancer|July 2, 2009
Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumoursV Gregorc, A Santoro, E Bennicelli, et al.
Leukemia|November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factorR Zanotti, A Ambrosetti, M Lestani, et al.
Pageof 13